SenesTech, Inc. (SNES): Price and Financial Metrics
GET POWR RATINGS... FREE!
SNES Stock Summary
- With a market capitalization of $2,997,195, SENESTECH INC has a greater market value than only 0.71% of US stocks.
- In terms of volatility of its share price, SNES is more volatile than 97.95% of stocks we're observing.
- Shareholder yield, a measure of how much is returned to shareholders via dividends and share repurchases, for SNES comes in at -140% -- higher than that of only 4.32% of stocks in our set.
- Stocks that are quantitatively similar to SNES, based on their financial statements, market capitalization, and price volatility, are ECOR, REFR, KVHI, RWLK, and PLAB.
- Visit SNES's SEC page to see the company's official filings. To visit the company's web site, go to www.senestech.com.
SNES Valuation Summary
- SNES's EV/EBIT ratio is 0.1; this is 99.09% lower than that of the median Basic Materials stock.
- SNES's price/earnings ratio has moved up 4.3 over the prior 77 months.
Below are key valuation metrics over time for SNES.
| Stock | Date | P/S | P/B | P/E | EV/EBIT |
|---|---|---|---|---|---|
| SNES | 2023-03-24 | 2.9 | 0.6 | -0.3 | 0.1 |
| SNES | 2023-03-23 | 2.9 | 0.6 | -0.3 | 0.1 |
| SNES | 2023-03-22 | 3.8 | 0.7 | -0.4 | 0.1 |
| SNES | 2023-03-21 | 3.4 | 0.7 | -0.4 | 0.1 |
| SNES | 2023-03-20 | 3.2 | 0.6 | -0.3 | 0.1 |
| SNES | 2023-03-17 | 3.3 | 0.6 | -0.4 | 0.1 |
SNES Growth Metrics
- Its 5 year revenue growth rate is now at -49.37%.
- The 4 year net cashflow from operations growth rate now stands at -19.19%.
- The 3 year price growth rate now stands at -98.5%.
The table below shows SNES's growth in key financial areas (numbers in millions of US dollars).
| Date | Revenue | Operating Cash Flow | Net Income to Common Stock |
|---|---|---|---|
| 2022-09-30 | 0.891 | -8.113 | -10.041 |
| 2022-06-30 | 0.824 | -7.926 | -9.648 |
| 2022-03-31 | 0.707 | -7.793 | -8.779 |
| 2021-12-31 | 0.6 | -7.779 | -8.268 |
| 2021-09-30 | 0.528 | -7.645 | -7.868 |
| 2021-06-30 | 0.422 | -7.536 | -7.534 |
SNES Price Target
For more insight on analysts targets of SNES, see our SNES price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.
| Average Price Target | $4.00 | Average Broker Recommendation | 1.5 (Moderate Buy) |
SNES Stock Price Chart Interactive Chart >
SNES Price/Volume Stats
| Current price | $1.49 | 52-week high | $16.00 |
| Prev. close | $1.52 | 52-week low | $1.31 |
| Day low | $1.45 | Volume | 56,900 |
| Day high | $1.53 | Avg. volume | 186,426 |
| 50-day MA | $2.48 | Dividend yield | N/A |
| 200-day MA | $5.96 | Market Cap | 3.06M |
SenesTech, Inc. (SNES) Company Bio
SenesTech, Inc. develops a technology for managing animal pest populations through fertility control. It develops a pipeline of fertility control and animal health products, such as ContraPest, plant-based fertility control, feral animal fertility control, non-surgical spay and neutering, boar taint, and animal cancer treatment. The company was founded in 2004 and is based in Flagstaff, Arizona.
Latest SNES News From Around the Web
Below are the latest news stories about SENESTECH INC that investors may wish to consider to help them evaluate SNES as an investment opportunity.
TIME Magazine Takes a Closer Look at ContraPest as a Solution to Global Rat InfestationsSenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), (www.senestech.com) the rodent fertility control experts and inventors of the only EPA registered contraceptive for male and female rats, ContraPest®, were featured in TIME Magazine as an innovative approach to dealing with global rat infestations. |
SenesTech, Inc. (NASDAQ:SNES) Q4 2022 Earnings Call TranscriptSenesTech, Inc. (NASDAQ:SNES) Q4 2022 Earnings Call Transcript March 16, 2023 Operator: Good afternoon and welcome to the SenesTech, Incorporated Fourth Quarter and Fiscal Year 2022 Financial Results Conference Call. Please note, this event is being recorded. I would now like to turn the conference over to Robert Blum with Lytham Partners. Please go ahead. […] |
Q4 2022 Senestech Inc Earnings CallQ4 2022 Senestech Inc Earnings Call |
SenesTech Announces 2022 Financial ResultsSenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), (www.senestech.com) the rodent fertility control experts and inventors of the only EPA-registered contraceptive for male and female rats, ContraPest®, today announced 2022 financial results, with products sales increasing 77% compared to the prior year. |
SenesTech Working with TriptoBIO on Biosynthetic TriptolideSenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), (www.senestech.com) the rodent fertility control experts and inventors of the only EPA registered contraceptive for male and female rats, ContraPest®, today confirmed news reports that the Company has been working with the Danish company TriptoBIO on the development of biosynthetic triptolide, one of the active ingredients in ContraPest. |
SNES Price Returns
| 1-mo | -28.71% |
| 3-mo | -51.78% |
| 6-mo | -78.74% |
| 1-year | -89.79% |
| 3-year | -96.40% |
| 5-year | -99.27% |
| YTD | -51.78% |
| 2022 | -84.22% |
| 2021 | -43.26% |
| 2020 | -84.32% |
| 2019 | -5.98% |
| 2018 | -18.75% |
Continue Researching SNES
Want to see what other sources are saying about SenesTech Inc's financials and stock price? Try the links below:SenesTech Inc (SNES) Stock Price | Nasdaq
SenesTech Inc (SNES) Stock Quote, History and News - Yahoo Finance
SenesTech Inc (SNES) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...